GE HealthCare Technologies GEHC Imaging — Cost of Sales
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by GE HealthCare Technologies in its filing.
Tagged under the XBRL concept us-gaap:CostOfRevenue.
The official record: GE HealthCare Technologies’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about GE HealthCare Technologies's imaging — cost of sales.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is GE HealthCare Technologies's imaging — cost of sales?
- GE HealthCare Technologies (GEHC) reported imaging — cost of sales of $1.54B in Q1 2026.
- How has GE HealthCare Technologies's imaging — cost of sales changed year-over-year?
- GE HealthCare Technologies's imaging — cost of sales increased by 14.0% year-over-year, from $1.35B to $1.54B.
- What is the long-term trend for GE HealthCare Technologies's imaging — cost of sales?
- Over 3 years (2022 to 2025), GE HealthCare Technologies's imaging — cost of sales has grown at a 2.5% compound annual growth rate (CAGR), from $5.66B to $6.1B.
- What does imaging — cost of sales mean?
- Includes the direct costs associated with manufacturing, assembling, and delivering imaging equipment, including raw materials, labor, and overhead. This metric is essential for calculating the gross margin of the Imaging segment. It provides insight into the efficiency of the segment's supply chain and production processes.